Phentolamine - Repros Therapeutics

Drug Profile

Phentolamine - Repros Therapeutics

Alternative Names: Vasofem; Vasomax; Z-MAX

Latest Information Update: 19 Nov 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Repros Therapeutics
  • Developer Industria Quimica e Farmaceutica Schering-Plough; Repros Therapeutics
  • Class Erectile dysfunction therapies; Eye disorder therapies; Imidazoles; Peripheral vasodilators; Small molecules
  • Mechanism of Action Alpha adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • Marketed Erectile dysfunction
  • Discontinued Female sexual dysfunction

Most Recent Events

  • 03 Nov 2003 Discontinued - Phase-I for Female sexual dysfunction in USA (PO)
  • 03 Nov 2003 Discontinued - Phase-I for Female sexual dysfunction in USA (Vaginal)
  • 03 Nov 2003 Discontinued - Preregistration for Erectile dysfunction in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top